Study Evaluating Rimonabant Efficacy in Drug-NAive DiabEtic Patients
NCT00257257
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
281
Enrollment
INDUSTRY
Sponsor class
Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG:
Rimonabant (SR141716)
Sponsor
Sanofi